Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 30;27(8):1215–1223. doi: 10.1093/ibd/izaa308

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

PMC Copyright notice

FIGURE 2. — Kaplan-Meier analysis for event-free survival of (A) composite effectiveness, (B) IBD-related surgery, (C) all-cause hospitalization, (D) treatment escalation, (E) clinical flare, and (F) disease complications. Composite effectiveness is the first of any IBD-related surgery, hospitalization from any cause, treatment escalation, or disease complication. Treatment escalation included any escalation in therapy to immunomodulating, biologic, combination thereof, or other immunosuppressing medications.